SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-243282
Filing Date
2017-08-01
Accepted
2017-08-01 08:15:57
Documents
3
Period of Report
2017-08-01
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d435122d8k.htm 8-K 16037
2 EX-99.1 d435122dex991.htm EX-99.1 10427
3 GRAPHIC g435122g44r11.gif GRAPHIC 5380
  Complete submission text file 0001193125-17-243282.txt   35092
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 17995060
SIC: 2836 Biological Products, (No Diagnostic Substances)